| Financial Year |
March 31 2022 |
| Monetary Funds |
347,038,041.17 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
58,620,303.80 |
| Advances to Suppliers |
6,505,186.79 |
| Other Receivables |
102,349,965.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
93,354,210.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
100,295,792.27 |
| Other Current Assets |
3,902,999.45 |
| Total Current Assets |
712,066,499.18 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
204,957,771.28 |
| Long-term Equity Investment |
19,251,952.13 |
| Investment Properties |
-- |
| Fixed Assetes |
41,113,550.50 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
734,603.35 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
60,706,635.25 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
331,333,937.41 |
| Total Assets |
1,043,400,436.59 |
| Short-Term Loans |
157,007,019.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
78,429,066.38 |
| Accounts Received In Advance |
216,886.67 |
| Employee Compensation Payable |
8,545,703.01 |
| Taxes Payable |
4,308,027.26 |
| Interest Payable |
31,382,156.75 |
| Dividend Payable |
240,900.00 |
| Other payables |
137,523,849.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,190,071.13 |
| Other Current Liabilities |
130,063,339.71 |
| Sub-Total of Current Liabilities |
546,767,829.87 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
55,745,751.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
56,239,808.99 |
| Total Liabilities |
603,007,638.86 |
| Paid-In Capital(Or Share Stock) |
2,178,303,106.00 |
| Capital Surplus |
1,422,223,740.68 |
| Surplus Reserve |
19,062,040.02 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,179,196,116.16 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
440,392,797.73 |
| Owner's Equity（Stockholder's Equity） |
440,392,797.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,043,400,436.59 |
